πŸ‡ΊπŸ‡Έ FDA
Patent

US 7652153

Caspase inhibitors and uses thereof

granted A61KA61K38/06A61P

Quick answer

US patent 7652153 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/06, A61P, A61P1/00, A61P1/04